Connect with us

Hi, what are you looking for?

Saturday, May 21, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Charlotte’s Web CBD gummies to launch at GNC stores in 24 US states

GNC has over 4,800 retail locations across America

The gummies target various wellness needs like better sleep and improved immune system functioning. Image via Charlotte's Web

Leading American CBD producer Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) is launching a line of health-focused gummies with supplement retail powerhouse GNC across the U.S.

On Tuesday, the Denver, Colorado-based cannabis company said an initial shipment of six gummy varieties will be in GNC stores across 24 states, with the intent to expand.

To best reach and serve consumers, Charlotte’s Web relies in part on strong partnership with proven mass retail partners, CEO Jacques Tortoroli says in a statement.

“GNC’s established retail footprint adds depth to our reach domestically and broadens consumer access to our high-quality hemp CBD products,” he says.

“We expect GNC will become one of our largest retail customers this year, and we are excited about the growth provided by bringing our two leading brands together.”

According to GNC’s website, it has over 4,800 retail locations in America, with franchise operations in 46 international markets.

The gummies are made with “full-spectrum” hemp extracts from its patented hemp cultivars. They’re vegan and non-GMO, featuring low concentrations of CBD with terpenes, flavonoids and other “beneficial” hemp compounds.

The products will feature other nutritional supplements to meet various wellness needs.

The six formulations include a raspberry-flavoured Sleep gummy with 10 milligrams of CBD and 3 milligrams of melatonin; a lemon berry-flavoured Immunity gummy with 10 milligrams of CBD, 90 milligrams of vitamin C and 70 milligrams of astragalus root; and a mango peach-flavoured THC-Free gummy with 15 milligrams of CBD “to support everyday wellness, whether on the job or at home.”

While major firms like Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) and Aurora Cannabis Inc. (TSX: ACB) have launched a number of CBD-based products in the U.S., the country has yet to approve a bill that regulates goods containing the cannabinoid.

Read more: Another bipartisan bill seeks to regulate CBD in US

Read more: US Senate bill would finally allow CBD in food and drinks

Another bipartisan effort to approve legislation kicked off in December, to put an end to the regulatory grey area.

The FDA has been promising a speedy process to create rules for CBD since 2019.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can


As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices


Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance


While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe